Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories (NY: BIO )

470.88 -9.61 (-2.00%)
Official Closing Price Updated: 7:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 92,788
Open 472.63
Bid (Size) 347.27 (1)
Ask (Size) 600.00 (1)
Prev. Close 480.49
Today's Range 470.00 - 479.03
52wk Range 344.63 - 670.62
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Thoughts For Thursday: All Eyes On The CPI
All eyes are on the release of the December Consumer Price Index data later today. 2023 has started as a relatively up year for equities and a continued downward trajectory seems necessary to keep the... 
Via Talk Markets
Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire

Performance

YTD
+11.47%
+11.47%
1 Month
+9.41%
+9.41%
3 Month
+24.28%
+24.28%
6 Month
-12.00%
-12.00%
1 Year
-24.86%
-24.86%

More News

Read More
Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio Rad Has Almost 40% Upside On Revenue Acceleration And Margin Improvement, Analyst Says
Via Benzinga
Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Third-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11
Via Benzinga
Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
Via Benzinga
Bio-Rad Acquires Curiosity Diagnostics
From Bio-Rad Laboratories, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Via Benzinga
Bio-Rad Laboratories: Q2 Earnings Insights
Via Benzinga
Bio-Rad Reports Second-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Tesla, Danaher And Some Other Big Gainers From Yesterday
Via Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Via Benzinga
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Jim Cramer Says This Stock Is 'Too Risky'
Via Benzinga
Bio-Rad Publishes Corporate Sustainability Report
From Bio-Rad Laboratories, Inc.
Via Business Wire
7 Profitable Places to Hide Your Money During a Bear Market
Via InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Recap: Bio-Rad Laboratories Q1 Earnings
Via Benzinga
Bio-Rad Reports First-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.